Shanghai Eight Plus One Pharmaceutical Co Ltd

BJY-803 was administered orally to healthy Chinese subjects multiple times after meals to evaluate the tolerability and pharmacokinetic characteristics of BJY-803 in healthy subjects, providing a basis for the formulation of subsequent clinical trial plans.

BJY-803 was orally administered to healthy Chinese subjects on an empty stomach and after a high-fat, high-calorie meal to evaluate the effect of food intake on the pharmacokinetics of BJY-803, providing a basis for the formulation of subsequent clinical trial plans.

The safety, tolerability and pharmacokinetic characteristics of a single dose of flavonol glycoside tablets in healthy Chinese subjects were evaluated by a single oral administration of flavonol glycoside tablets in healthy subjects, providing a basis for the formulation of subsequent clinical trial plans.